SIRT1 and polycystic ovary syndrome: Emerging evidence identifies the SIRT1/AMPK axis as a pivotal molecular mechanism underlying IR in PCOS, with resveratrol’s glucoregulatory effects partially attributed to its activation of this pathway (28).